Chemoinformaics analysis of Taxifolin-3-glucoside
| Molecular Weight | 466.395 | nRot | 4 |
| Heavy Atom Molecular Weight | 444.219 | nRig | 6 |
| Exact Molecular Weight | 466.111 | nRing | 4 |
| Solubility: LogS | -2.905 | nHRing | 2 |
| Solubility: LogP | 3.115 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 12 | APOL | 59.3634 |
| nHD | 8 | BPOL | 28.1466 |
| QED | 0.476 |
| Synth | 1.034 |
| Natural Product Likeliness | -0.694 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.04 |
| HIA | 0.003 |
| CACO-2 | -4.245 |
| MDCK | 0.0000278 |
| BBB | 0.844 |
| PPB | 0.890021 |
| VDSS | 2.662 |
| FU | 0.119491 |
| CYP1A2-inh | 0.928 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.761 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.192 |
| CYP2c9-sub | 0.721 |
| CYP2d6-inh | 0.095 |
| CYP2d6-sub | 0.907 |
| CYP3a4-inh | 0.079 |
| CYP3a4-sub | 0.443 |
| CL | 10.483 |
| T12 | 0.619 |
| hERG | 0.028 |
| Ames | 0.055 |
| ROA | 0.038 |
| SkinSen | 0.434 |
| Carcinogencity | 0.702 |
| EI | 0.997 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.821502 |